Effect of 1-(4-amino-2-methyl-5-pyrimidinyl)methyl-3-(2-chloroethyl)-3-nitrosourea hydrochloride on experimental brain tumors.
D000818:Animals; D000970:Antineoplastic Agents / Q000627:therapeutic use*; D001932:Brain Neoplasms / Q000188:drug therapy*; D002460:Cell Line; D004353:Drug Evaluation, Preclinical; D004806:Ependymoma / Q000188:drug therapy; D005910:Glioma / Q000188:drug therapy; D051379:Mice; D008810:Mice, Inbred C57BL; D009362:Neoplasm Metastasis; D009374:Neoplasms, Experimental / Q000188:drug therapy*; D009607:Nitrosourea Compounds / Q000627:therapeutic use*; D013936:Thymidine / Q000378:metabolism
D000970:Antineoplastic Agents; D009607:Nitrosourea Compounds; D013936:Thymidine